Back to search

Article

GRHL2 is a Candidate Prognostic and Immunotherapy Biomarker in Breast Cancer

2021-10-25

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>:Breast cancer (BC) is the most frequent malignancy in women worldwide and the leading cause of female cancer‐associated death in the world. Thus, we need to identify new biomarkers to predict the prognosis of BC. In mammals, the Grainyhead-like (GRHL) family of transcription factors has three members, called Grainyhead-like 1 (GRHL1), Grainyhead-like 2 (GRHL2) an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c08ce021-a004-5d72-8b2f-806fdf89841f
DOI
10.21203/rs.3.rs-999774/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
GRHL2 is a Candidate Prognostic and Immunotherapy Biomarker in Breast CancerDOI 10.21203/rs.3.rs-999774/v1
Select a neighboring publication to make it the new centre.